Hyperfine, Inc.
Hyperfine, Inc. (HYPR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HYPR · as of Jun 9, 2026
Key Statistics
Explore Hyperfine, Inc. Data
hypr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The HYPR analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $1.60, representing +13.48% upside from the current price of $1.41.
Competitors & Peers
hypr competitorsHYPR
CNTB
EDAP
FONR
IMA
LUNGStock Performance
Full HistoryAbout Hyperfine, Inc.
Hyperfine, Inc. Headquartered in Guilford, Connecticut, Hyperfine, Inc. commenced operations in 2014. The firm develops and supplies imaging, monitoring, and magnetic resonance imaging (MRI) technologies. A key offer…
what is hyperfine, inc. · hypr stock overview · hyperfine, inc. company profile · who is hyperfine, inc. ceo · hypr NASDAQ · hyperfine, inc. headquarters · hyperfine, inc. business segments
About Stock Overview & Key Data
Hyperfine, Inc. (HYPR) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jan 28, 2021. As of the latest trading session, HYPR stock price is $1.41, with a market capitalization of $118.7M. The stock has returned +82.12% over the past 12 months and +43.98% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Hyperfine, Inc. stock is Buy, with an average 12-month price target of $1.60. In fiscal year 2025, Hyperfine, Inc. reported revenue of $13.6M and net income of -$35.6M. For detailed data — including Hyperfine, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hyperfine, Inc. (HYPR) stock price is $1.41. The stock is traded on NASDAQ under the ticker symbol HYPR. The 52-week range is $0.66 – $2.22.